Holen Sie sich die Stockscreener-App
0.66
0.92%
0.006
Passage Bio Inc Aktie (PASG) Neueste Nachrichten
Orbimed advisors sells $51,988 in Passage Bio shares By Investing.com - Investing.com South Africa
Orbimed advisors sells $51,988 in Passage Bio shares - Investing.com India
Orbimed Advisors LLC Reduces Stake in Passage Bio Inc - GuruFocus.com
WuXi Firms Surge on Slimmer Chances of US Biosecure Passage | Stock Market News - Mint
WuXi Firms Surge on Slimmer Chances of US Biosecure Passage - Yahoo Finance
ORBIMED ADVISORS LLC Reduces Holdings in Passage Bio Inc - GuruFocus.com
Orbimed advisors sells Passage Bio shares worth $77,338 By Investing.com - Investing.com Australia
Orbimed advisors sells Passage Bio shares worth $77,338 - Investing.com
Erste Asset Management GmbH Takes Position in Passage Bio, Inc. (NASDAQ:PASG) - MarketBeat
Yun Zhong, PhD, Joins Wedbush Securities as Senior Vice President, Equity Research, Biotechnology - Financial Times
Layoff Tracker: Agenus to Lay Off Staff as Part of Cost-Cutting Moves - BioSpace
Passage Bio assumed with an Outperform at Wedbush - Yahoo Finance
Gene and Cell Therapies Targeting CNS Disorders Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - The Globe and Mail
Gene and Cell Therapies Targeting CNS Disorders Treatment - openPR
Passage Bio sees $284,519 in stock purchases by Lynx1 Capital - Investing.com South Africa
Insider Activity Roundup: Wednesday's Top Buys and Sells Revealed By Investing.com - Investing.com Canada
Insider Activity Roundup: Wednesday's Top Buys and Sells Revealed - Investing.com
Lynx1 Capital Management LP Increases Stake in Passage Bio Inc - GuruFocus.com
Passage Bio CEO Will Chou to Share Insights at Guggenheim Healthcare Innovation Conference! - MSN
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOn November 13, 2024, Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company focusing on innovative therapies for rare cardiopulmonary dise - Defense World
Horizon Space Acquisition I Corp. Approved for Listing on Nasdaq Capital Market - Defense World
Seres Therapeutics Receives Notification from Nasdaq Regarding Bid Price Requirement - Defense World
BioRestorative Therapies Provides Business Update and Financial Results for Q3 2024 - Defense World
Metal Sky Star Acquisition Amends Investment Management Trust Agreement and Extends Business Combination Period - Defense World
Nikola Corporation Enters Material Definitive Agreements, Modifies Convertible Notes – 8-K Filing Highlights - Defense World
Air Industries Group to Release Financial Results for Q3 2024 - Defense World
AgriFORCE Growing Systems Announces Strategic Shift Towards Sustainable Technology Initiatives - Defense World
Cognition Therapeutics Reports Financial Results for the Third Quarter 2024UNAUDITED – On November 13, 2024, Cognition Therapeutics, Inc. (NASDAQ: CGTX) disclosed its financial results for the third quarter ending September 30, 2024. Within the detai - Defense World
Orange County Bancorp, Inc. (NASDAQ: OBT) Distributes Investor Presentation and Financial Disclosure - Defense World
Digital Brands Group (NASDAQ: DBGI) Announces Strategic Partnership with VaynerCommerce - Defense World
MRC Global Inc. Enters into Fifth Amended and Restated Loan Agreement - Defense World
Intevac (NASDAQ: IVAC) Enters into Letter Agreement with Palogic Value Management, L.P.Santa Clara, CA, November 13, 2024 – Intevac, Inc. (NASDAQ: IVAC) disclosed today in a Form 8-K filing that on November 8, 2024, the company entered into a letter - Defense World
Advance Auto Parts Enters Amendment to Credit Agreement - Defense World
Sound Point Meridian Capital, Inc. (NYSE: SPMC) Announces Financial Results for Quarter Ended September 30, 2024 - Defense World
Tetra Tech Reports Record Fiscal 2024 and Fourth Quarter ResultsOn November 13, 2024, Tetra Tech, Inc. (NASDAQ: TTEK) released its financial results for the fourth fiscal quarter and the fiscal year ended September 29, 2024. According to the report - Defense World
Roth CH Acquisition II Files 8-K Report with SEC Detailing Company Updates and Investor Presentation - Defense World
Capricor Therapeutics Announces Financial Results for Third Quarter 2024 and Strategic DevelopmentsSAN DIEGO, November 13, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) recently disclosed its financial outcomes for the third - Defense World
Predictive Oncology Inc. Issues Press Release Detailing Financial Results for Q3 2024Predictive Oncology Inc., a leading biopharmaceutical company, released a pivotal press release detailing its financial results for the quarter ending September 30 - Defense World
Flutter Entertainment Announces Launch of Share Repurchase Program - Defense World
374Water Inc. Reports Third Quarter 2024 Results and Business Update - Defense World
Broadwind, Inc. Reports Financial Results for Quarter Ending September 30, 2024 - Defense World
Workhorse Group Reschedules Earnings Call to November 19, 2024 - Defense World
Cabaletta Bio Reports Q3 2024 Financial Results and Clinical Trial Advancements - MyChesCo
Passage Bio stock hits 52-week low at $0.54 amid market challenges - Investing.com India
Passage Bio Advances PBFT02 Gene Therapy Program Amidst Positive Q3 2024 Results - MSN
Vestal Point Capital, LP Increases Stake in Passage Bio Inc - GuruFocus.com
Passage Bio Achieves Milestones in Gene Therapy Trials - Yahoo Finance
Passage Bio Shows Progress in Gene Therapy Trials - TipRanks
PASGPassage Bio, Inc. Latest Stock News & Market Updates - StockTitan
Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewswire
Passage Bio's Q3 Shows Progress: Clinical Trial Advances, Cash Runway Extended to 2026 | PASG Stock News - StockTitan
Annovis Bio Advances Alzheimer’s Treatment with Phase 3 Trials and Financial Updates - MyChesCo
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):